Arkolith/Insider Trading/RLMD/Form 4

Traversa Sergio

Chief Executive Officer, DirectorRELMADA THERAPEUTICS, INC. (RLMD) · full profile →Form 4 · filed Aug 28, 2025
Net Buying
Open-Market Buys
$178K
Open-Market Sells
$0
Net Open-Market Flow
$178K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 28, 2025Buy(P)56K$0.74$41K1.0M
Aug 27, 2025Buy(P)129K$0.67$87K944K
Aug 26, 2025Buy(P)81K$0.62$50K815K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-081837) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML